title: Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?
abstract: CONCLUSIONS
  Oxidative stress has been mechanistically linked with aging and chronic diseases, including cancer. In fact, oxidative stress status, chronic disease-related inflammation, and cancer occurred in the aging population are tightly correlated. It is well known that the activation of nuclear factor kappa B (NF-κB) plays important roles in oxidative stress, inflammation, and carcinogenesis. Therefore, targeting NF-κB is an important preventive or therapeutic strategy against oxidative stress, inflammation, and cancer.
  
  
  BACKGROUND
  A variety of natural compounds has been found to reduce oxidative stress through their antioxidant activity. Among them, isoflavone, indole-3-carbinol (I3C), and its in vivo dimeric compound 3,3'-diindolylmethane (DIM) have shown their promising effects on the inhibition of NF-κB with corresponding reduction of oxidative stress.
  
  
  RESULTS
  It has been found that isoflavone, I3C, and DIM could inhibit cancer development and progression by regulating multiple cellular signaling pathways that are related to oxidative stress and significantly deregulated in cancer.
  
  
  CONCLUSIONS
  The antioxidative and anticancer effects of these natural agents make them strong candidates for chemoprevention and/or therapy against human malignancies. However, more clinical trials are needed to evaluate the effects of isoflavone and DIM for the prevention of cancer development and also for the treatment of cancer either alone or in combination with conventional cancer therapeutics.
authors: Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
authors: Yiwei
authors: Y
authors: Li
authors: Dejuan
authors: D
authors: Kong
authors: Aamir
authors: A
authors: Ahmad
authors: Bin
authors: B
authors: Bao
authors: Fazlul H
authors: FH
authors: Sarkar
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D001685:Biological Factors / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D007529:Isoflavones / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D000975:Antioxidants; D001685:Biological Factors; D007211:Indoles; D007529:Isoflavones; C016392:3,3'-diindolylmethane
references: Mol Carcinog. 2002 Jun;34(2):91-101
references: 12112315
references: Carcinogenesis. 2009 Feb;30(2):331-9
references: 19073877
references: Toxicol Appl Pharmacol. 2011 Jul 15;254(2):86-99
references: 21296097
references: Acta Pharmacol Sin. 2004 May;25(5):666-71
references: 15132835
references: Prostate. 2007 Apr 1;67(5):521-35
references: 17252539
references: J Thorac Oncol. 2011 Apr;6(4):688-98
references: 21325978
references: Nutr Cancer. 1999;35(2):167-74
references: 10693171
references: Nature. 2003 Jun 5;423(6940):596-7
references: 12789323
references: Anticancer Res. 2010 Jun;30(6):2049-54
references: 20651350
references: Cancer Prev Res (Phila). 2011 Sep;4(9):1495-506
references: 21680704
references: Clin Cancer Res. 2004 Aug 15;10(16):5501-7
references: 15328189
references: Mol Cancer Ther. 2006 Mar;5(3):483-93
references: 16546962
references: Trends Mol Med. 2002 Aug;8(8):385-9
references: 12127724
references: World J Gastroenterol. 2004 Jun 15;10(12):1822-5
references: 15188515
references: J Nutr. 2003 Apr;133(4):1011-9
references: 12672912
references: Clin Cancer Res. 2002 Apr;8(4):1228-36
references: 11948137
references: J Androl. 1994 Jan-Feb;15(1):41-51
references: 7514587
references: J Nutr. 2003 Jul;133(7 Suppl):2448S-2455S
references: 12840223
references: Cancer. 2006 Feb 1;106(3):599-608
references: 16388521
references: Nutr Cancer. 2003;45(1):101-12
references: 12791510
references: Cancer Res. 1990 May 1;50(9):2618-24
references: 2158395
references: Crit Rev Oncol Hematol. 2002 Apr;42(1):93-103
references: 11923071
references: Free Radic Res. 2001 Jan;34(1):101-12
references: 11234992
references: Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a000141
references: 20066113
references: Cancer. 2003 Dec 1;98(11):2511-20
references: 14635088
references: Free Radic Biol Med. 2001 Sep 1;31(5):651-8
references: 11522450
references: Cancer Lett. 2009 Jun 28;279(1):8-12
references: 19022563
references: Cancer Lett. 2011 Jun 28;305(2):250-62
references: 21093147
references: Cancer Res. 2009 Jul 1;69(13):5592-600
references: 19531648
references: Teratog Carcinog Mutagen. 2002;22(3):227-34
references: 11948633
references: Cancer Res. 2005 Oct 1;65(19):9064-72
references: 16204081
references: Cell Res. 2011 Jan;21(1):103-15
references: 21187859
references: Drug Discov Today. 2002 Jun 15;7(12):653-63
references: 12110242
references: J Cell Biochem. 2010 May;110(1):171-81
references: 20213764
references: Mutat Res. 1999 Jul 15;443(1-2):37-52
references: 10415430
references: Free Radic Biol Med. 2011 Jan 15;50(2):228-36
references: 21034812
references: Biochem Pharmacol. 2003 Sep 15;66(6):1009-18
references: 12963487
references: Free Radic Biol Med. 2001 Jun 1;30(11):1293-302
references: 11368927
references: Am J Transl Res. 2010 Jul 23;2(4):402-11
references: 20733950
references: Cancer Lett. 1999 Nov 15;146(2):161-7
references: 10656621
references: Nature. 2000 Nov 9;408(6809):239-47
references: 11089981
references: Leukemia. 2012 Apr;26(4):806-13
references: 21946908
references: Clin Cancer Res. 2005 Feb 1;11(3):1287-93
references: 15709200
references: J Clin Invest. 2005 Oct;115(10):2625-32
references: 16200195
references: Clin Cancer Res. 2002 May;8(5):949-61
references: 12006506
references: Cancer Lett. 2009 Jun 18;278(2):201-209
references: 19231069
references: Carcinogenesis. 2012 Jan;33(1):77-83
references: 22095071
references: Am J Pathol. 2009 Aug;175(2):489-99
references: 19628766
references: Free Radic Res. 1997 Jan;26(1):63-70
references: 9018473
references: Biochem Pharmacol. 2002 Sep;64(5-6):765-70
references: 12213568
references: Oncogene. 2001 May 24;20(23):2927-36
references: 11420705
references: Free Radic Biol Med. 2001 Dec 15;31(12):1570-81
references: 11744331
references: EMBO J. 1999 May 17;18(10):2803-11
references: 10329626
references: J Natl Cancer Inst. 1998 Mar 4;90(5):381-8
references: 9498488
references: Am J Transl Res. 2012;4(1):14-23
references: 22347519
references: Mol Nutr Food Res. 2006 Apr;50(4-5):368-72
references: 16534752
references: Nat Rev Immunol. 2005 Oct;5(10):749-59
references: 16175180
references: Mol Carcinog. 2010 Jul;49(7):672-83
references: 20564344
references: Mol Cancer Res. 2006 Oct;4(10):715-28
references: 17050666
references: Nutr Cancer. 1993;20(1):1-12
references: 8415125
references: Cancer Res. 2006 May 1;66(9):4816-25
references: 16651437
references: Nutr Cancer. 1999;34(1):12-9
references: 10453436
references: Mol Cancer Ther. 2008 Jun;7(6):1708-19
references: 18566242
references: Eur J Nutr. 2011 Jun;50(4):219-33
references: 21547407
references: Physiol Genomics. 2007 Jun 19;30(1):8-16
references: 17341692
references: J Surg Res. 2011 Jul;169(1):e37-42
references: 21529826
references: Cancer Res. 2007 Apr 1;67(7):3310-9
references: 17409440
references: Oncol Res. 2004;14(11-12):567-78
references: 15666998
references: J Nutr. 2002 Dec;132(12):3623-31
references: 12468598
references: Free Radic Biol Med. 2002 May 1;32(9):797-803
references: 11978481
references: Nutr Cancer. 1998;31(3):184-91
references: 9795970
references: Nat Rev Cancer. 2002 Apr;2(4):301-10
references: 12001991
references: J Biol Chem. 2007 Jul 20;282(29):21542-50
references: 17522055
references: J Biol Chem. 2000 May 12;275(19):14624-31
references: 10799549
references: For Immunopathol Dis Therap. 2010;1(3):155-181
references: 21686046
references: Oncogene. 1999 May 20;18(20):3166-72
references: 10340389
references: Cancer Res. 2005 Aug 1;65(15):6934-42
references: 16061678
references: Am J Pathol. 1999 Aug;155(2):473-81
references: 10433940
references: J Biol Chem. 2003 Jun 6;278(23):21136-45
references: 12665522
references: Cancer. 2004 Nov 15;101(10):2351-62
references: 15476283
references: Mol Cancer Ther. 2007 Nov;6(11):3071-9
references: 18025290
references: Cancer Res. 2009 Aug 1;69(15):6083-91
references: 19622773
references: J Nutr. 2008 Jan;138(1):17-23
references: 18156398
references: Nature. 1999 Sep 2;401(6748):86-90
references: 10485711
references: Toxicol Appl Pharmacol. 2004 Jul 1;198(1):40-8
references: 15207647
references: Cancer Lett. 2012 May 1;318(1):86-92
references: 22155105
references: Biochem Pharmacol. 2000 Jan 1;59(1):13-23
references: 10605930
references: Inflamm Bowel Dis. 2009 Aug;15(8):1164-73
references: 19334074
references: J Clin Invest. 1997 Dec 15;100(12):2961-9
references: 9399941
references: Mol Med Today. 2000 Nov;6(11):441-8
references: 11074370
references: J Neurochem. 2011 Dec;119(5):909-19
references: 21781119
references: Oncogene. 2003 May 1;22(17):2611-20
references: 12730675
references: Trends Mol Med. 2011 Jul;17(7):395-403
references: 21376665
references: Biofactors. 2001;15(2-4):87-9
references: 12016332
references: Nutr Cancer. 2004;48(1):84-94
references: 15203382
references: Int J Oncol. 1999 Sep;15(3):525-33
references: 10427135
references: Front Biosci. 2005 Jan 01;10:236-43
references: 15574364
references: Oncogene. 2003 Jul 24;22(30):4702-9
references: 12879015
references: Mol Cancer Ther. 2010 Nov;9(11):3003-14
references: 20978159
references: Mol Cell Endocrinol. 1993 Dec;98(1):17-25
references: 8143910
references: Leukemia. 2002 Jun;16(6):1053-68
references: 12040437
references: Cell. 2007 Jun 29;129(7):1261-74
references: 17604717
references: Mol Cell Endocrinol. 2003 Mar 28;201(1-2):1-12
references: 12706288
references: Cancer Res. 2006 Oct 15;66(20):10064-72
references: 17047070
references: J Biol Chem. 2002 May 10;277(19):16639-47
references: 11872748
references: J Neurosci Res. 2000 Jul 1;61(1):21-32
references: 10861796
references: Colorectal Dis. 2002 May;4(3):205-207
references: 12780618
references: Nat Rev Drug Discov. 2011 Jun;10(6):453-71
references: 21629295
references: Am J Pathol. 2006 Nov;169(5):1833-42
references: 17071604
references: Int J Cancer. 2004 Oct 10;111(6):961-7
references: 15300810
references: J Nutr. 2003 Jul;133(7 Suppl):2434S-2439S
references: 12840220
references: Int J Vitam Nutr Res. 2002 Jan;72(1):26-31
references: 11887749
references: J Clin Invest. 2001 Jan;107(2):135-42
references: 11160126
references: Chem Biol Interact. 1997 Feb 28;103(2):79-129
references: 9055870
references: Ann N Y Acad Sci. 1993 May 28;686:186-201; discussion 201-2
references: 8512247
references: Comp Biochem Physiol A Mol Integr Physiol. 2003 Sep;136(1):113-26
references: 14527634
references: J Clin Immunol. 2005 Nov;25(6):541-50
references: 16380818
references: Biochem Pharmacol. 2002 Sep;64(5-6):883-8
references: 12213582
references: Cancer Lett. 2011 Feb 1;301(1):75-84
references: 21078540
references: Lung Cancer. 2010 Dec;70(3):263-70
references: 20338663
references: J Biol Chem. 2008 Oct 10;283(41):27707-27716
references: 18687691
references: Cancer Res. 2001 Aug 15;61(16):6120-30
references: 11507062
references: Biochim Biophys Acta. 2003 Oct 20;1630(1):35-40
references: 14580677
references: Clin Cancer Res. 2002 Jul;8(7):2369-77
references: 12114442
references: Cancer Lett. 2002 Dec 5;186(2):157-64
references: 12213285
references: Biochem Mol Biol Int. 1996 Aug;39(6):1125-34
references: 8876965